NPJ Precis Oncol. 2026 May 11. doi: 10.1038/s41698-026-01472-4. Online ahead of print.
ABSTRACT
Accurate prediction of recurrence risk is essential to devise effective and personalized treatment strategies for patients with soft tissue sarcoma (STS). This study aimed to develop and validate a multimodal deep learning framework that integrates clinical features, preoperative MR images, and hematoxylin and eosin-stained whole slide images (WSIs) to predict recurrence in patients with STS. A total of 323 patients with STS were retrospectively enrolled from two hospitals, serving as development and validation sets, respectively. The ShuffleNetV2 network was utilized to develop patch-level and WSI-level signatures. A convolutional neural network fusing the channel and spatial attention mechanisms was used to develop a radiology signature. The combined model was built by integrating clinical features, radiology signature score, and WSI-level signature score with Cox regression analysis. The combined model demonstrated superior performance in the validation set, achieving a C-index of 0.857 and a time-dependent area under the curve of 0.959. Class activation maps facilitated the monitoring of suspected regions to inform recurrence decisions. The recurrence-free survival times of the low- and high-risk cohorts were statistically different (p < 0.05). The proposed multimodal framework offers satisfactory accuracy for predicting recurrence risk in patients with STS and could guide the choice of treatment modality.
PMID:42115754 | DOI:10.1038/s41698-026-01472-4
